Recent achievements
In 2014, the group was involved in four EU-applications. We published 20 papers in peer-review journals, and filed one DOFI. We published miRNA-data on lung adenocarcinomas, identifying miRNA-signatures for EGFR-mutated samples, in addition to a miRNA with prognostic impact. We published molecular signatures of mRNA and miRNA as prognostic markers in pancreatic cancer, and plasma miRNAs predicting clinical outcome in colorectal cancer. We published data on methylation changes during radiotherapy of breast cancers, influencing therapy effect.
We arranged a regional lung cancer meeting with appr 100 participants. We have had talks at national and international meetings, and are PIs on several translational and clinical studies. Currently 17 clinical studies for lung cancer patients are ongoing.
We arranged a regional lung cancer meeting with appr 100 participants. We have had talks at national and international meetings, and are PIs on several translational and clinical studies. Currently 17 clinical studies for lung cancer patients are ongoing.